Bioactive lipid

Bioactive lipids are a diverse group of signaling molecules, including eicosanoids, sphingolipids, and lysophospholipids, that regulate fundamental cellular processes such as proliferation, apoptosis, and metabolism (Hannun & Obeid, 2008, Nature Reviews Molecular Cell Biology). These molecules function primarily as ligands for specific G protein-coupled receptors (GPCRs) or as secondary messengers within intracellular signaling pathways (Wymann & Schneiter, 2008, Nature Reviews Molecular Cell Biology). In pathological contexts, dysregulated bioactive lipid signaling is a hallmark of chronic inflammation, cardiovascular disease, and various cancers, where they often promote tumor growth and immune evasion (Wang & DuBois, 2010, Nature Reviews Cancer). Pharmacological intervention typically involves the use of small molecules to inhibit biosynthetic enzymes, such as cyclooxygenases (COX) or lipoxygenases (LOX), or to modulate the activity of their cognate receptors, such as the sphingosine-1-phosphate (S1P) receptors (Spiegel & Milstien, 2003, Nature Reviews Molecular Cell Biology). While highly effective, targeting these pathways can lead to significant side effects, including gastrointestinal distress or cardiovascular complications, due to the pleiotropic roles of these lipids in maintaining physiological homeostasis (Funk, 2001, Science).

Other names

Lipid mediatorsSignaling lipidsBioactive lipid mediators

Bioactive lipids are targeted through the inhibition of their biosynthetic enzymes (e.g., COX-1, COX-2, 5-LOX), the antagonism or modulation of their specific G protein-coupled receptors (e.g., S1PR1, CysLT1), or the direct sequestration of the lipid species using monoclonal antibodies (e.g., sonepcizumab for S1P).